|
|
|
|
|
|
Psoriasis: Health Advances developed a detailed commercialization plan for a novel agent targeting psoriasis. The plan highlighted the market
opportunity, product positioning strategies, clinical trial plans, and sales and marketing requirements for the novel agent. The company used the Health
Advances analysis to support business development activities and maximize the value of the program.
Platelet Concentrators for Wound Healing: As part of an acquisition candidate search, Health Advances evaluated the market dynamics surrounding
platelet concentration systems in plastics and orthopedic surgeries. The study considered use of Platelet Rich Plasma (PRP) as a wound healing sealant,
soft-tissue growth factor, and as an agent to augment bone repair.
Laser-Based Acne Therapy: Health Advances investigated both the reimbursed path and the self-pay path for a novel laser-based therapy intended
to displace some of the most expensive drug regimens. Although acne is a covered medical necessity, we discovered that it would be better for the company to
rely on self-pay patients.
Laser-Based Therapy Onychomycosis: Health Advances evaluated the commercial potential for a novel laser-based treatment for onychomycosis.
The project included in-depth physician interviews, rigorous competitor analysis, and market sizing.
Product for Treatment of Diabetic Foot Ulcers: Health Advances conducted due diligence on a product used in diabetic foot ulcers. Primary research
with users focused on determining the decision-making process in choosing wound healing products and identifying current treatment paradigms.
|
|
 |
|
|
|
|
